StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
65
This year
2
Publishing Date
2023 - 11 - 02
1
2023 - 10 - 17
1
2023 - 09 - 19
1
2023 - 09 - 10
1
2023 - 09 - 05
1
2023 - 08 - 29
1
2023 - 08 - 21
1
2023 - 08 - 11
1
2023 - 08 - 09
1
2023 - 07 - 25
1
2023 - 07 - 21
1
2023 - 06 - 23
1
2023 - 05 - 30
1
2023 - 05 - 24
1
2023 - 05 - 09
1
2023 - 05 - 05
1
2023 - 04 - 26
1
2023 - 04 - 25
1
2023 - 04 - 03
1
2023 - 03 - 06
1
2023 - 02 - 21
1
2023 - 02 - 14
1
2023 - 02 - 03
1
2023 - 02 - 01
1
2023 - 01 - 19
1
2022 - 12 - 22
1
2022 - 12 - 21
1
2022 - 12 - 12
1
2022 - 12 - 05
2
2022 - 12 - 02
1
2022 - 10 - 25
1
2022 - 10 - 05
1
2022 - 09 - 22
1
2022 - 09 - 07
1
2022 - 09 - 02
1
2022 - 08 - 31
1
2022 - 07 - 20
1
2022 - 05 - 25
1
2022 - 05 - 19
1
2022 - 05 - 16
1
2022 - 04 - 20
1
2022 - 03 - 14
1
2022 - 03 - 02
1
2022 - 03 - 01
1
2022 - 02 - 14
1
2022 - 01 - 21
1
2021 - 12 - 29
1
2021 - 12 - 10
1
2021 - 11 - 23
1
2021 - 11 - 01
1
2021 - 09 - 20
1
2021 - 09 - 19
1
2021 - 06 - 24
1
2021 - 06 - 01
1
2021 - 04 - 20
1
2021 - 04 - 10
1
2021 - 03 - 31
1
2021 - 03 - 23
1
2021 - 03 - 10
1
2021 - 01 - 04
1
Sector
Consumer services
1
Finance
5
Health services
2
Health technology
65
Miscellaneous
1
Professional, scientific, and technical services
1
Tags
Acquired
1
Acquisition
1
Advanced
1
Agreement
2
Alliances
4
America
1
Application
3
Approval
2
Artificial intelligence
1
Asco
2
Authorization
1
Biocapital
1
Biomarkers
2
Bioscience
3
Biotech-beach
12
Biotechnology
3
Breakthrough therapy
1
Cancer
32
Cancer drug
1
Care
2
Cel
1
Cell
4
Collaboration
5
Colorectal cancer
2
Conference
11
Designation
2
Diagnostic
3
Drug
5
Earnings
2
Events
2
Fda
5
Financial
7
Financial results
5
Food
3
Global
3
Grant
6
Health
3
Krasg12
12
Lung
11
Lung cancer
7
N/a
65
Nasdaq
5
New drug
2
Offering
4
Pharm-country
2
Phase 1
2
Positive
4
Report
8
Research
7
Results
25
Sapphire
2
Study
4
System
2
Test
3
Therapeutics
49
Therapy
4
Treatment
9
Tumors
4
Update
3
World
2
Entities
Abbvie inc.
1
Absci corp
1
Agenus inc.
1
Amgen inc.
2
Biontech se
1
Blueprint medicines corporation
2
Bristol-myers squibb company
5
Corcept therapeutics incorporated
1
Eli lilly and company
1
Firstcash, inc.
1
Genmab a/s
1
Incyte corporation
2
Karuna therapeutics, inc.
3
Kura oncology, inc.
1
Merck & company, inc.
1
Merrimack pharmaceuticals, inc.
1
Mirati therapeutics, inc.
65
Moderna, inc.
1
Morgan stanley
4
Neogenomics, inc.
1
Novocure limited
2
Oak street health, inc.
1
Oncolytics biotech inc.
2
Oric pharmaceuticals, inc.
1
Purple innovation, inc.
1
Revolution medicines, inc.
1
Rollins, inc.
1
Sanofi
2
Seagen inc.
2
Seer inc - class a
1
Zai lab limited
5
Symbols
AAPL
1191
ABB
1423
ABBV
783
ABLZF
1162
ABT
1561
ACN
600
AMGN
569
ARVL
4166
AVGO
582
BDX
690
BNPQF
1736
BNPQY
1736
CSCO
894
DELL
575
DHR
725
DOW
554
ERIC
1595
EXTR
581
F
636
FNCTF
6832
FRBA
594
GE
885
GLAXF
615
GOOG
1056
GOOGL
1056
GSK
788
HON
1778
HUBS
1400
IBM
651
INTC
946
IT
589
JNJ
2883
LLY
1119
LMT
575
LTUM
970
LYV
717
MDT
1147
MMM
926
MS
3850
MSFT
1191
MT
587
NOC
588
NOK
899
NOKBF
973
NVS
1115
NVSEF
945
ORCL
1154
PCRFF
650
PCRFY
650
PHG
956
PPRUF
1061
PPRUY
1062
SAP
1473
SAPGF
1228
SNOW
794
SNY
2815
SNYNF
2232
TMO
1408
VZ
1202
XYF
652
Exchanges
Nasdaq
65
Nyse
12
Crawled Date
2023 - 11 - 02
1
2023 - 10 - 17
1
2023 - 09 - 19
1
2023 - 09 - 10
1
2023 - 09 - 05
1
2023 - 08 - 29
1
2023 - 08 - 21
1
2023 - 08 - 11
1
2023 - 08 - 09
1
2023 - 07 - 25
1
2023 - 07 - 21
1
2023 - 06 - 23
1
2023 - 05 - 30
1
2023 - 05 - 24
1
2023 - 05 - 09
1
2023 - 05 - 05
1
2023 - 04 - 26
1
2023 - 04 - 25
1
2023 - 04 - 03
1
2023 - 03 - 06
1
2023 - 02 - 21
1
2023 - 02 - 14
1
2023 - 02 - 03
1
2023 - 02 - 01
1
2023 - 01 - 19
1
2022 - 12 - 22
1
2022 - 12 - 21
1
2022 - 12 - 13
1
2022 - 12 - 06
2
2022 - 12 - 02
1
2022 - 10 - 25
1
2022 - 10 - 05
1
2022 - 09 - 22
1
2022 - 09 - 07
1
2022 - 09 - 02
1
2022 - 08 - 31
1
2022 - 07 - 20
1
2022 - 05 - 25
1
2022 - 05 - 19
1
2022 - 05 - 16
1
2022 - 04 - 20
1
2022 - 03 - 14
1
2022 - 03 - 02
1
2022 - 03 - 01
1
2022 - 02 - 14
1
2022 - 01 - 21
1
2021 - 12 - 30
1
2021 - 12 - 10
1
2021 - 11 - 23
1
2021 - 11 - 01
1
2021 - 09 - 20
1
2021 - 09 - 19
1
2021 - 06 - 24
1
2021 - 06 - 01
1
2021 - 04 - 20
1
2021 - 04 - 10
1
2021 - 03 - 31
1
2021 - 03 - 23
1
2021 - 03 - 10
1
2021 - 01 - 04
1
Crawled Time
00:00
3
01:00
1
04:20
1
05:00
1
12:00
5
12:30
1
13:00
3
13:15
1
13:20
1
15:30
1
16:00
1
16:20
1
17:00
1
19:00
1
20:00
11
20:20
1
21:00
16
22:00
8
22:04
1
23:00
5
23:07
1
Source
www.globenewswire.com
8
www.prnewswire.com
57
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
N::A
symbols :
MRTX
save search
Corcept Appoints Roberto Vieira as President, Oncology
Published:
2024-01-29
(Crawled : 13:00)
- globenewswire.com
CORT
M
|
$23.0
-1.67%
-1.7%
960K
|
Health Technology
|
7.99%
|
O:
0.6%
H:
2.48%
C:
2.48%
European Commission Approves KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation
Published:
2024-01-10
(Crawled : 13:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
-0.31%
|
O:
0.02%
H:
0.17%
C:
-0.19%
krasg12
lung
cancer
cell
treatment
advanced
Mirati Therapeutics Receives Positive Opinion from CHMP for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation Following a Re-Examination Procedure
Published:
2023-11-10
(Crawled : 12:30)
- prnewswire.com
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-4.27%
|
O:
0.4%
H:
0.18%
C:
0.0%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
4.61%
|
O:
-0.11%
H:
0.0%
C:
0.0%
krasg12
lung
chmp
positive
cancer
cell
treatment
therapeutics
Zai Lab Announces Third Quarter 2023 Financial Results and Recent Corporate Updates
Published:
2023-11-07
(Crawled : 21:00)
- globenewswire.com
GNMSF
|
$285.11
3.83%
420
|
Health Technology
|
-3.35%
|
O:
6.62%
H:
2.29%
C:
-0.06%
ZLAB
|
$13.75
-4.65%
-4.87%
400K
|
Health Technology
|
-51.54%
|
O:
8.3%
H:
0.02%
C:
-2.12%
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
6.91%
|
O:
0.49%
H:
0.0%
C:
-0.57%
NVCR
|
$12.04
-3.37%
-3.49%
1.4M
|
Health Technology
|
-6.37%
|
O:
0.7%
H:
0.0%
C:
-6.94%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
4.89%
|
O:
0.29%
H:
0.21%
C:
-0.48%
KRTX
|
$329.83
0.0%
1.9M
|
Health Technology
|
83.73%
|
O:
0.27%
H:
0.14%
C:
-3.34%
GMAB
|
$28.51
-3.13%
-3.23%
360K
|
Health Technology
|
-3.35%
|
O:
7.35%
H:
0.44%
C:
-2.18%
results
Kura Oncology and Mirati Therapeutics Enter into Clinical Collaboration and Supply Agreement to Evaluate KO-2806 and Adagrasib in KRASᴳ¹²ᶜ-Mutated NSCLC
Published:
2023-11-02
(Crawled : 12:00)
- globenewswire.com
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-5.89%
|
O:
-0.9%
H:
1.08%
C:
0.61%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
5.41%
|
O:
0.2%
H:
0.43%
C:
-0.38%
KURA
|
$18.0
-3.17%
-3.28%
660K
|
Health Technology
|
125.16%
|
O:
0.13%
H:
6.0%
C:
5.25%
ko-2806
collaboration
therapeutics
agreement
Mirati Presents Late-Breaking Results Evaluating the Combination of Adagrasib and Pembrolizumab in First-Line Non-Small Cell Lung Cancer (NSCLC)
Published:
2023-10-17
(Crawled : 20:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
3.98%
|
O:
-0.04%
H:
0.35%
C:
-0.53%
lung
cancer
cell
results
Pancreatic Cancer Battle Boosted by $200M VC Firm
Published:
2023-09-19
(Crawled : 17:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-46.08%
|
O:
-1.47%
H:
4.98%
C:
3.98%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
84.91%
|
O:
-0.13%
H:
2.0%
C:
1.83%
MACK
4
|
$14.68
0.0%
100K
|
Health Technology
|
19.93%
|
O:
-0.41%
H:
0.9%
C:
0.74%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-11.41%
|
O:
0.03%
H:
2.18%
C:
1.8%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-20.82%
|
O:
-0.01%
H:
1.99%
C:
1.28%
cancer
pancreatic
Mirati Presents Two-Year Follow-Up Data from KRYSTAL-1 Study Demonstrating Durable Response and Long-Term Overall Survival at 2023 World Conference on Lung Cancer
Published:
2023-09-10
(Crawled : 04:20)
- prnewswire.com
MS
|
News
0 d
|
$90.08
1.06%
-0.28%
9.5M
|
Finance
|
Email alert
Add to watchlist
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
Email alert
Add to watchlist
lung
conference
world
cancer
response
study
Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Published:
2023-09-05
(Crawled : 20:00)
- prnewswire.com
MS
|
News
0 d
|
$90.08
1.06%
-0.28%
9.5M
|
Finance
|
5.17%
|
O:
-1.87%
H:
0.0%
C:
0.0%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
64.44%
|
O:
0.36%
H:
0.86%
C:
-1.17%
nasdaq
grant
therapeutics
Mirati Therapeutics to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference
Published:
2023-08-29
(Crawled : 20:00)
- prnewswire.com
MS
|
News
0 d
|
$90.08
1.06%
-0.28%
9.5M
|
Finance
|
6.87%
|
O:
1.44%
H:
0.0%
C:
0.0%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
61.37%
|
O:
0.69%
H:
1.04%
C:
1.01%
conference
global
therapeutics
Mirati To Present Pooled Clinical Data from Adagrasib's KRYSTAL-1 Study Demonstrating Overall Survival Results at Two-Years of Follow-Up at 2023 World Conference on Lung Cancer
Published:
2023-08-21
(Crawled : 20:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
55.36%
|
O:
0.5%
H:
1.29%
C:
-1.02%
lung
conference
world
cancer
results
study
Mirati Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Published:
2023-08-11
(Crawled : 20:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
Email alert
Add to watchlist
offering
therapeutics
Mirati Therapeutics Announces Pricing of Upsized Public Offering
Published:
2023-08-09
(Crawled : 05:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
109.7%
|
O:
23.42%
H:
8.46%
C:
6.87%
offering
therapeutics
Mirati Therapeutics® to Report Second Quarter 2023 Financial Results and Recent Corporate Updates on August 8, 2023
Published:
2023-07-25
(Crawled : 21:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
92.47%
|
O:
0.29%
H:
0.0%
C:
-2.19%
therapeutics
report
financial
results
Mirati Therapeutics Provides Update on Regulatory Review in the European Union of KRAZATI (adagrasib) for the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRAS G12C Mutation
Published:
2023-07-21
(Crawled : 12:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
73.97%
|
O:
-14.97%
H:
11.97%
C:
8.9%
lung
review
update
cancer
cell
treatment
therapeutics
Mirati Therapeutics Appoints Industry Veteran Carol Gallagher, Pharm.D. as New Independent Director
Published:
2023-06-23
(Crawled : 20:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
Email alert
Add to watchlist
therapeutics
Mirati To Encore Compelling Clinical Data Demonstrating Adagrasib's Potential as a Targeted Treatment for KRASG12C-Mutated Advanced Solid Tumors at 2023 ASCO Annual Meeting
Published:
2023-05-30
(Crawled : 20:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
58.54%
|
O:
0.43%
H:
2.55%
C:
-0.27%
krasg12
asco
tumors
treatment
meeting
potential
Mirati Therapeutics Provides Update on the Phase 3 SAPPHIRE Study Evaluating Sitravatinib in Combination with OPDIVO®
Published:
2023-05-24
(Crawled : 20:00)
- prnewswire.com
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-26.29%
|
O:
-0.81%
H:
0.32%
C:
-0.59%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
34.17%
|
O:
-6.18%
H:
0.0%
C:
-6.64%
opdivo
update
sapphire
therapeutics
study
Zai Lab Announces First Quarter 2023 Financial Results and Corporate Updates
Published:
2023-05-09
(Crawled : 20:00)
- globenewswire.com
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
11.64%
|
O:
-0.21%
H:
0.32%
C:
-0.07%
ZLAB
|
$13.75
-4.65%
-4.87%
400K
|
Health Technology
|
-61.2%
|
O:
4.89%
H:
6.5%
C:
1.13%
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
14.37%
|
O:
0.17%
H:
0.07%
C:
-0.17%
NVCR
|
$12.04
-3.37%
-3.49%
1.4M
|
Health Technology
|
-82.79%
|
O:
1.11%
H:
1.89%
C:
0.97%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
24.33%
|
O:
-2.41%
H:
5.41%
C:
3.75%
KRTX
|
$329.83
0.0%
1.9M
|
Health Technology
|
51.29%
|
O:
1.07%
H:
1.21%
C:
0.62%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-18.6%
|
O:
0.29%
H:
0.07%
C:
-1.6%
BPMC
|
$88.395
2.68%
2.61%
730K
|
Health Technology
|
58.75%
|
O:
1.36%
H:
0.13%
C:
-1.89%
results
Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Published:
2023-05-05
(Crawled : 20:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
Email alert
Add to watchlist
nasdaq
grant
therapeutics
← Previous
1
2
3
4
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.